Minocycline in Major Depressive Disorder: And overview with considerations on treatment-resistance and comparisons with other psychiatric disorders

Evidence on the link between the immune system and Major Depressive Disorder (MDD) has led to explore antidepressant properties of anti-inflammatory drugs. Among these, minocycline has been identified as a potential novel treatment for MDD, in particular for treatment-resistant depression. The aim o...

Descripción completa

Detalles Bibliográficos
Autor principal: Nettis, Maria Antonietta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Articles from the Special Issue on Emerging PNI research: future leaders in focus; Edited by Amanda Kentner, Lois Harden, Denis de Melo Soares and Christoph Rummel
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7611693/
https://www.ncbi.nlm.nih.gov/pubmed/34568852
http://dx.doi.org/10.1016/j.bbih.2021.100335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7611693/
https://www.ncbi.nlm.nih.gov/pubmed/34568852
http://dx.doi.org/10.1016/j.bbih.2021.100335

Ejemplares similares